Lack of sleep and untreated depression may increase the risk of Alzheimer's disease

September 2, 2016 by Jean Milán
Lack of sleep and untreated depression may increase the risk of Alzheimer’s disease

New research suggests that lack of sleep and untreated depression may increase the risk of Alzheimer's disease, even for those who do not have a genetic predisposition for the disease.

Depression and sleeplessness have long been considered symptoms of Alzheimer's disease. This study indicates that whether in combination with genetic risk factors or on their own, untreated depression and lack of sleep may lead to the onset of Alzheimer's disease dementia later in life.

"Previous research has attempted to explore the relationship between depression, sleep disturbance and Alzheimer's disease. Our research is significant in that it is the first to find an increased risk of Alzheimer's disease due to insomnia and depression independently, as well as in combination with genetic risk factors," said Shanna L. Burke, assistant professor of at the FIU Robert Stempel College of Public Health & Social Work.

Alzheimer's disease currently affects more than 39.9 million people worldwide. In the United States, it is the most common form of dementia in the elderly, affecting 1 in 10 people over the age of 65.

Although treating the for Alzheimer's disease isn't possible yet, these findings suggest that alleviating depression and sleep disturbance may decrease the chances of a person developing the disease.

Burke served as the primary investigator for the study. She and the other members of the research team—Peter Maramaldi, Tamara Cadet and Walter Kukull—present their findings in Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia, which was recently highlighted as "Paper of the Month" in the journal International Psychogeriatrics. Commentary and associated findings on the study were provided by Dr. David Steffens, chair of the department of psychiatry at the University of Connecticut.

"Future studies are needed to better understand the role of sleep in development of Alzheimer's Disease, either as an independent risk factor or as a key depressive symptom that might further unlock the link between depression and Alzheimer's," said Steffens.

Burke specializes in investigating genetic and psychosocial associated with the development of neurodegenerative diseases. Her research analyzes clinical, neuropathological and genetic data collected by sites across the United States. She teaches courses on research methodology, assessment and intervention, and gerontology at FIU.

Explore further: New genetic risk marker for late-life depression

More information: Shanna L. Burke et al. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia, International Psychogeriatrics (2016). DOI: 10.1017/S1041610216000405

Related Stories

New genetic risk marker for late-life depression

November 3, 2015
One of the most powerful predictors in neuropsychiatry is the epsilon 4 (ε4) allele of the apolipoprotein gene (APOE).

Western diet increases Alzheimer's risk

August 26, 2016
Globally, about 42 million people now have dementia, with Alzheimer's disease as the most common type of dementia. Rates of Alzheimer's disease are rising worldwide. The most important risk factors seem to be linked to diet, ...

Antipsychotic medications linked to increased risk of pneumonia in persons with Alzheimer's disease

August 30, 2016
Antipsychotic medications are associated with an increased risk of pneumonia in persons with Alzheimer's disease (AD), according to new research from the University of Eastern Finland. The risk of pneumonia was the highest ...

Researchers clarify relationships between diabetes and two cognitive disorders

August 31, 2016
Researchers in the University of Kentucky College of Public Health and UK College of Medicine recently published a landmark study examining the relationships between diabetes and two types of cognitive dysfunction, Alzheimer's ...

Antidepressant use begins years before Alzheimer's diagnosis

March 4, 2016
Antidepressants are frequently prescribed to persons with Alzheimer's disease before the diagnosis, according to a recent study from the University of Eastern Finland. Among persons with Alzheimer's disease, the initiation ...

Recommended for you

New mechanism detected in Alzheimer's disease

October 13, 2017
McGill University researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer's disease.

Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease

October 13, 2017
Microglia, immune cells that act as the central nervous system's damage sensors, have recently been implicated in Alzheimer's disease.

Green tea extract delivers molecular punch to disrupt formation of neurotoxic species

October 11, 2017
Green tea is widely considered to be beneficial for the brain. The antioxidant and detoxifying properties of green tea extracts help fight catastrophic diseases such as Alzheimer's. However, scientists have never fully understood ...

Menopause triggers metabolic changes in brain that may promote Alzheimer's

October 10, 2017
Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer's disease, a team from Weill Cornell Medicine and the University of Arizona Health Sciences has shown in new research.

Being unaware of memory loss predicts Alzheimer's disease, new study shows

October 10, 2017
While memory loss is an early symptom of Alzheimer's disease, its presence doesn't mean a person will develop dementia. A new study at the Centre for Addiction and Mental Health (CAMH) has found a clinically useful way to ...

Alzheimer's gene poses both risk and benefits

October 9, 2017
Scientists drilling down to the molecular roots of Alzheimer's disease have encountered a good news/bad news scenario. A major player is a gene called TREM2, mutations of which can substantially raise a person's risk of the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.